CIPLA1,374.00

Cipla Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹1.11L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment5,069.05,262.36,039.86,039.8
+ Capital Work-in-Progress864.31,212.81,586.31,586.3
+ Investment Property113.6111.30.00.0
+ Goodwill3,112.03,270.33,754.43,754.4
+ Other Intangibles1,312.61,362.62,640.12,640.1
+ Intangibles under Development288.4353.5455.9455.9
+ Investments (Equity Method)130.1140.5111.8111.8
+ Non-current Investments512.2499.1432.2432.2
+ Long-term Loans17.032.52.82.8
+ Other Non-current Financial Assets508.6283.51,194.11,194.1
Non-current Financial Assets1,037.7815.11,629.11,629.1
+ Deferred Tax Assets587.8644.9901.0901.0
+ Other Non-current Assets760.9925.51,230.51,230.5
Total Non-current Assets13,276.414,098.518,349.018,349.0
Current Assets
+ Inventories5,238.05,642.16,596.76,596.7
+ Current Investments4,807.07,293.27,679.47,679.4
+ Trade Receivables4,770.75,506.45,620.15,620.1
+ Cash & Cash Equivalents640.1588.71,018.21,018.2
+ Other Bank Balances234.9211.2289.2289.2
+ Short-term Loans0.215.623.123.1
+ Other Current Financial Assets2,801.52,936.91,460.21,460.2
Current Financial Assets13,254.416,552.016,090.216,090.2
+ Other Current Assets900.11,054.91,458.91,458.9
Total Current Assets19,392.523,249.024,145.924,145.9
Total Assets32,717.837,387.042,496.042,496.0
Equity
+ Equity Share Capital161.5161.5161.6161.6
+ Other Equity / Reserves26,545.031,031.934,270.434,270.4
Equity — Owners of Parent26,706.431,193.534,432.034,432.0
+ Minority Interest95.995.888.388.3
Total Equity26,802.331,289.334,520.234,520.2
Liabilities
+ Borrowings — Non-current0.012.0117.5117.5
+ Other Non-current Financial Liab293.2342.9484.9484.9
Non-current Financial Liabilities293.2354.9602.4602.4
+ Provisions — Non-current129.3148.7157.6157.6
+ Deferred Tax Liabilities185.353.5153.3153.3
+ Other Non-current Liabilities61.956.849.049.0
Non-current Liabilities669.7613.8962.2962.2
+ Borrowings — Current247.080.1140.5140.5
+ Trade Payables2,474.02,837.53,229.93,229.9
+ Other Current Financial Liab579.1480.11,078.11,078.1
Current Financial Liabilities3,300.13,397.84,448.54,448.5
+ Provisions — Current1,611.81,716.62,259.22,259.2
+ Current Tax Liabilities22.076.85.55.5
+ Other Current Liabilities311.9292.9300.5300.5
Current Liabilities5,245.85,484.07,013.67,013.6
Total Liabilities5,915.56,097.87,975.77,975.7
Total Equity & Liabilities32,717.837,387.042,496.042,496.0
Assets — additional as-filed lines
+ Non-current Assets Held for Sale49.039.61.21.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current278.6215.2215.2
+ Dues to Other Creditors — Current2,558.93,014.73,014.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.